Previous close | 42.28 |
Open | 42.34 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 42.34 - 42.41 |
52-week range | 28.10 - 45.76 |
Volume | |
Avg. volume | 42,658 |
Market cap | 1.594B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 34.76 |
EPS (TTM) | 1.22 |
Earnings date | 21 May 2024 - 27 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 10 Dec 2018 |
1y target est | 43.00 |
NEW YORK, May 08, 2024--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
NEW YORK, April 15, 2024--Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.